首页 | 本学科首页   官方微博 | 高级检索  
检索        

6种用药方案治疗化疗药物相关性肝损害的经济学评价
引用本文:孙桂君,王艳.6种用药方案治疗化疗药物相关性肝损害的经济学评价[J].中国药房,2009(17):1281-1283.
作者姓名:孙桂君  王艳
作者单位:哈尔滨医科大学附属肿瘤医院药学部,哈尔滨市150086
摘    要:目的:评价6种用药方案治疗化疗药物相关性肝损害的经济学效果。方法:将应用化疗药物引起肝功能异常的269例恶性肿瘤患者随机分为A、B、C、D、E、F组,分别应用注射用还原型谷胱甘肽钠、甘草酸二铵注射液、复方甘草酸苷注射液、多烯磷脂酰胆碱注射液、复方二氯醋酸二异丙胺注射液、注射用复方甘草酸单铵S治疗,观察疗效,并进行成本-效果分析。结果:A、B、C、D、E、F组总有效率分别为91.67%、75.00%、86.05%、84.78%、87.50%、85.42%,成本分别为798.28、311.08、859.88、918.68、1092.28、1319.08元,成本-效果比分别为870.82、414.77、999.28、1083.60、1248.32、1544.23;A、C、D、E、F组相对于B组的增量成本-效果比分别为2922.62、4966.52、6212.68、6249.60、9673.70。结论:A组方案为治疗化疗药物相关性肝损害安全、有效、经济的方案。

关 键 词:化疗药物相关性肝损害  经济学评价  用药方案

Economic Evaluation on 6 Therapeutic Schemes for Hepatic Lesion Induced by Chemotherapeutic Drugs
SUN Gui-jun,WANG Yan.Economic Evaluation on 6 Therapeutic Schemes for Hepatic Lesion Induced by Chemotherapeutic Drugs[J].China Pharmacy,2009(17):1281-1283.
Authors:SUN Gui-jun  WANG Yan
Institution:(Dept. of Pharmacy, The Tumor Hospital of Harbin Medical University, Harbin 150086, China)
Abstract:OBJECTIVE: To evaluate the economic efficacy of 6 therapeutic schemes for hepatic lesions induced by chemotherapeutic drugs. METHODS: A total of 269 malignant tumor patients complicating hepatic lesion because of using of chemotherapeutic drugs were randomly divided into 6 groups (A, B, C, D, E and F) to be treated with Reduced Glutathione Sodium for Injection, Diammonium Glycyrrhizinate Injection, Compound Glyeyrrhizin Injection, Polyene Phosphatidylcholine Injection, Compound Diisopropylamine Dichloroacetate Injection, Compound Ammonium Glycyrrhetate Injection, respective- ly. The curative effects were recorded and the cost- effectiveness analysis was conducted. RESULTS: In A, B, C, D, E and F groups, the effective rates were 91.67%, 75.00%, 86.05%, 84.78%, 87.50% and 85.42%, respectively, the costs were 798.28 yuan, 311,08 yuan, 859.88 yuan, 918.68 yuan, 1 092.28 yuan and 1 319.08 yuan, respectively, and the cost - effec- tiveness ratios were: 870.82, 414.77, 999.28, 1 083.60, 1 248.32 and i 544.23, respectively. The incremental cost - effec- tiveness ratios for A, C, D, E, F groups as against group B were 2 922.62, 4 966.52, 6 212.68, 6 249.60 and 9 673.70, re- spectively. CONCLUSION: Group A was proved to be the safe, effective and economical therapeutic scheme for hepatic lesions induced by chemotherapeutic drugs.
Keywords:Hepatic lesion induced by chemotherapeutic drugs  Economic evaluation  Therapeutic scheme
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号